$14.26
Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
Overview
52-week range
$11
$23
24% of range
Avg surprise (last 3)
+101.0%
Avg reaction (last 2)
+2.7%
100% positive
Latest IV / EM
59%
EM ±9.3% · $15 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.12 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | $-0.08 | $-0.17 | +52.9% | -300.0% | +0.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.18 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.12 | $0.04 | +200.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.02 | $-0.04 | +50.0% | — | +5.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.12 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.10 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.04 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.15 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.20 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $849M | $811M | — | $822M | $826M | $776M | — | $770M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $102M | $66M | — | $106M | $112M | $62M | — | $61M |
| Net income | $-15M | $-36M | — | $-23M | $-2M | $-38M | — | $-32M |
| EPS (diluted) | $-0.12 | $-0.28 | — | $-0.18 | $-0.02 | $-0.30 | — | $-0.25 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $217M | $182M | $240M | $203M | $250M | $229M | $270M | $222M |
| Inventory | $99M | $100M | $97M | $92M | $87M | $88M | $88M | $82M |
| Total current assets | $1.13B | $1.08B | $1.15B | $1.10B | $1.11B | $1.07B | $1.12B | $1.04B |
| Total assets | $8.05B | $8.04B | $8.12B | $7.95B | $7.95B | $7.95B | $7.89B | $7.53B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $1.67B | $3.10B | $1.71B | $1.73B | $3.16B | $3.16B | $1.79B | $3.11B |